Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.
D000818:Animals; D001419:Bacteria / Q000187:drug effects; D001426:Bacterial Proteins / Q000096:biosynthesis; D055598:Chemical Phenomena; D002621:Chemistry; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D056890:Eukaryota / Q000187:drug effects; D005658:Fungi / Q000187:drug effects; D008958:Models, Molecular; D009696:Nucleic Acids / Q000096:biosynthesis; D012995:Solubility; D013045:Species Specificity; D014769:Virginiamycin / Q000032:analysis / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use
D001426:Bacterial Proteins; D009696:Nucleic Acids; D014769:Virginiamycin